BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12539246)

  • 1. Correlation between prostate cancer grade and vascularity on color doppler imaging: preliminary findings.
    Tang J; Li S; Li J; Luo Y; Xu J; Zhang Y; Li X; Shi H; Zhang G
    J Clin Ultrasound; 2003 Feb; 31(2):61-8. PubMed ID: 12539246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score.
    Mitterberger M; Pinggera GM; Horninger W; Bartsch G; Strasser H; Schäfer G; Brunner A; Halpern EJ; Gradl J; Pallwein L; Frauscher F
    J Urol; 2007 Aug; 178(2):464-8; discussion 468. PubMed ID: 17561137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score.
    Nelson ED; Slotoroff CB; Gomella LG; Halpern EJ
    Urology; 2007 Dec; 70(6):1136-40. PubMed ID: 18158034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic cancer: role of color Doppler imaging in transrectal sonography.
    Lavoipierre AM; Snow RM; Frydenberg M; Gunter D; Reisner G; Royce PL; Lavoipierre GJ
    AJR Am J Roentgenol; 1998 Jul; 171(1):205-10. PubMed ID: 9648790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site.
    Newman JS; Bree RL; Rubin JM
    Radiology; 1995 Apr; 195(1):86-90. PubMed ID: 7534429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings.
    Cornud F; Hamida K; Flam T; Hélénon O; Chrétien Y; Thiounn N; Correas JM; Casanova JM; Moreau JF
    AJR Am J Roentgenol; 2000 Oct; 175(4):1161-8. PubMed ID: 11000183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of resistance index in patients with prostate cancer.
    Huang ST; Hsieh ML
    Anticancer Res; 2008; 28(4A):1985-8. PubMed ID: 18649736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival.
    Ismail M; Petersen RO; Alexander AA; Newschaffer C; Gomella LG
    Urology; 1997 Dec; 50(6):906-12. PubMed ID: 9426722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers.
    Kuligowska E; Barish MA; Fenlon HM; Blake M
    Radiology; 2001 Sep; 220(3):757-64. PubMed ID: 11526279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound.
    Cho JY; Kim SH; Lee SE
    Eur Urol; 2000 Apr; 37(4):443-8. PubMed ID: 10765075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer.
    Strohmeyer D; Frauscher F; Klauser A; Recheis W; Eibl G; Horninger W; Steiner H; Volgger H; Bartsch G
    Anticancer Res; 2001; 21(4B):2907-13. PubMed ID: 11712785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.
    Pelzer A; Bektic J; Berger AP; Pallwein L; Halpern EJ; Horninger W; Bartsch G; Frauscher F
    J Urol; 2005 Jun; 173(6):1926-9. PubMed ID: 15879783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of color Doppler and staging biopsies in prostate cancer detection.
    Bree RL
    Urology; 1997 Mar; 49(3A Suppl):31-4. PubMed ID: 9123733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Color and power Doppler sonography in the diagnosis of prostate cancer: comparison between vascular density and total vascularity.
    Arger PH; Malkowicz SB; VanArsdalen KN; Sehgal CM; Holzer A; Schultz SM
    J Ultrasound Med; 2004 May; 23(5):623-30. PubMed ID: 15154528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Color Doppler quantitative measures to predict outcome of biopsies in prostate cancer.
    Strigari L; Marsella A; Canitano S; Gomellini S; Arcangeli S; Genovese E; Saracino B; Petrongari MG; Sentinelli S; Crecco M; Benassi M; Arcangeli G
    Med Phys; 2008 Nov; 35(11):4793-9. PubMed ID: 19070211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of transrectal ultrasound imaging of the prostate.
    Aigner F; Mitterberger M; Rehder P; Pallwein L; Junker D; Horninger W; Frauscher F
    J Endourol; 2010 May; 24(5):685-91. PubMed ID: 20433367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of examining blood supply in prostate cancer using Doppler frequency analysis.
    Zát'ura F; Student V
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():93-5. PubMed ID: 10743734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
    Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible use of transrectal power Doppler imaging as an indicator of microvascular density of prostate cancer.
    Nakanouchi T; Okihara K; Kojima M; Ukimura O; Yokoyama K; Takamatsu T; Miki T
    Urology; 2001 Oct; 58(4):573-7. PubMed ID: 11597542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The correlations between color Doppler using a contrast medium and the neoangiogenesis of small prostatic carcinomas].
    Lagalla R; Caruso G; Urso R; Bizzini G; Marasà L; Miceli V
    Radiol Med; 2000 Apr; 99(4):270-5. PubMed ID: 10884828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.